Friday, November 5, 2021
2:30PM – 3:30PM ET
Please note this virtual program is 2:30PM Eastern, 1:30PM Central, 12:30PM Mountain and 11:30AM Pacific.
FACULTY
Michael Wechsler, MD
Professor of Medicine-National Jewish Health
Director, National Jewish Cohen Family Asthma Institute
Denver, CO
TARGET AUDIENCE
This CME activity is designed to meet the educational needs of pulmonologists, allergists, primary care physicians, pediatricians, and other health care providers involved in the management of patients with severe uncontrolled asthma.
LEARNING OBJECTIVES
On completing the program, attendees should be able to:
- Assess disease severity and intensify therapy as needed to manage the symptoms and quality-of-life issues associated with uncontrolled severe asthma in pediatric and adult patients
- Utilize biomarkers and asthma phenotypes to personalize the selection of treatment options for pediatric and adult patients with severe asthma
- Incorporate current treatment recommendations and clinical trial data for the management of severe asthma into clinical practice
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group will designate each virtual live meeting and simulcast for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the live-virtual activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with severe asthma.
CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
